In this episode of OncoDaily, childhood cancer care and the role of global collaboration in improving outcomes are discussed. Manette le Grange, Corporate Social Responsibility Lead at Servier Pharmaceuticals, and Sean Lybrand, Executive Director of Access to Healthcare at Amgen, share insights into their work within the Act for Children initiative — a global public-private partnership focused on improving outcomes for children with cancer in low- and middle-income countries.
The conversation highlights:
• The importance of health system strengthening before access to medicines
• Why collaboration across industry, NGOs, and global organizations is essential
• How initiatives like World Health Organization-supported programs and St. Jude Children’s Research Hospital Global are advancing access to childhood cancer medicines
• The shift from “hand-outs” to sustainable “hand-ups” and long-term system integration
• Real-world implementation in Yerevan, Armenia and its role as a model for other countries
• Why improving even small percentages in survival can have a massive impact on children’s lives